Resultats de la cerca - Antoszyk An
- Mostrar 1 - 20 resultats de 51
- Anar a la pàgina següent
-
1
-
2
-
3
-
4
-
5
-
6
-
7
-
8
SCORE Study Report 7: Incidence of Intravitreal Silicone Oil Droplets Associated With Staked-on Versus Luer Cone Syringe Design per Scott, Ingrid U., Oden, Neal L., VanVeldhuisen, Paul C., Ip, Michael S., Blodi, Barbara A., Antoszyk, Andrew N.
Publicat 2009Text -
9
Characterization of novel microsphere chain fiber optic tips for potential use in ophthalmic laser surgery per Hutchens, Thomas C., Darafsheh, Arash, Fardad, Amir, Antoszyk, Andrew N., Ying, Howard S., Astratov, Vasily N., Fried, Nathaniel M.
Publicat 2012Text -
10
A Randomized Trial Comparing Intravitreal Triamcinolone and Focal/Grid Photocoagulation for Diabetic Macular Edema: Baseline Features per Ip, Michael S., Bressler, Susan B., Antoszyk, Andrew N., Flaxel, Christina J., Kim, Judy E., Friedman, Scott M., Qin, Haijing
Publicat 2008Text -
11
EVALUATION OF FULL-FIELD ELECTRORETINOGRAM REDUCTIONS AFTER OCRIPLASMIN TREATMENT: Results of the OASIS Trial ERG Substudy per Birch, David G., Benz, Matthew S., Miller, Daniel M., Antoszyk, Andrew N., Markoff, Joseph, Kozma, Petra, Meunier, Esmeralda, Sergott, Robert C.
Publicat 2018Text -
12
-
13
Visual acuity outcomes after anti-VEGF treatment for neovascular age-related macular degeneration: AREDS2 Report Number 19 per Keenan, Tiarnan D., Vitale, Susan, Agrón, Elvira, Domalpally, Amitha, Antoszyk, Andrew N., Elman, Michael J., Clemons, Traci E., Chew, Emily Y.
Publicat 2019Text -
14
Observational Study of the Development of Diabetic Macular Edema Following Panretinal (Scatter) Photocoagulation Given in 1 or 4 Sittings per Brucker Aj, Hong Qin, Antoszyk An, Beck Rw, Bressler Nm, Browning DJ, Michael J. Elman, Adam R. Glassman, Gross Jg, Craig Kollman, Wells Ja
Publicat 2009Artigo -
15
Baseline Factors Associated With 6-Month Visual Acuity and Retinal Thickness Outcomes in Patients With Macular Edema Secondary to Central Retinal Vein Occlusion or Hemiretinal Vein... per Scott, Ingrid U., VanVeldhuisen, Paul C., Ip, Michael S., Blodi, Barbara A., Oden, Neal L., King, Jacqueline, Antoszyk, Andrew N., Peters, Mark A., Tolentino, Michael
Publicat 2017Text -
16
Visual Acuity, Vitreous Hemorrhage, and Other Ocular Outcomes After Vitrectomy vs Aflibercept for Vitreous Hemorrhage Due to Diabetic Retinopathy: A Secondary Analysis of a Randomi... per Glassman, Adam R., Beaulieu, Wesley T., Maguire, Maureen G., Antoszyk, Andrew N., Chow, Clement C., Elman, Michael J., Jampol, Lee M., Salehi-Had, Hani, Sun, Jennifer K.
Publicat 2021Text -
17
Phase 1 Study of OPT-302 Inhibition of Vascular Endothelial Growth Factors C and D for Neovascular Age-Related Macular Degeneration per Pravin U. Dugel, David S. Boyer, Andrew N. Antoszyk, Nathan Steinle, Michael P. Varenhorst, Joel Pearlman, Mark C. Gillies, Robert P. Finger, Megan E. Baldwin, Ian M. Leitch
Publicat 2019Artigo -
18
Five-Year Outcomes after Initial Aflibercept, Bevacizumab, or Ranibizumab Treatment for Diabetic Macular Edema (Protocol T Extension Study) per Glassman, Adam R., Wells, John A., Josic, Kristin, Maguire, Maureen G., Antoszyk, Andrew N., Baker, Carl, Beaulieu, Wesley T., Elman, Michael J., Jampol, Lee M., Sun, Jennifer K.
Publicat 2020Text -
19
Five-Year Outcomes after Initial Aflibercept, Bevacizumab, or Ranibizumab Treatment for Diabetic Macular Edema (Protocol T Extension Study) per Adam R. Glassman, John A. Wells, Kristin Josic, Maureen G. Maguire, Andrew N. Antoszyk, Carl W. Baker, Wesley T. Beaulieu, Michael J. Elman, Lee M. Jampol, Jennifer K. Sun
Publicat 2020Artigo -
20
Effect of Intravitreous Aflibercept vs Vitrectomy With Panretinal Photocoagulation on Visual Acuity in Patients With Vitreous Hemorrhage From Proliferative Diabetic Retinopathy per Andrew N. Antoszyk, Adam R. Glassman, Wesley T. Beaulieu, Lee M. Jampol, Chirag Jhaveri, Omar S. Punjabi, Hani Salehi-Had, John A. Wells, Maureen G. Maguire, Cynthia R. Stockdale, Daniel Martín, Jennifer K. Sun
Publicat 2020Artigo
Eines de cerca:
Matèries relacionades
Medicine
Ophthalmology
Visual acuity
Diabetes mellitus
Diabetic retinopathy
Endocrinology
Internal medicine
Surgery
Bevacizumab
Chemotherapy
Macular edema
Aflibercept
Ranibizumab
Diabetic macular edema
Macular degeneration
Randomized controlled trial
Clinical trial
Retinal
Retinopathy
Edema
Optometry
Confidence interval
Panretinal photocoagulation
Biology
Carotenoid
Clinical endpoint
Degeneration (medical)
Dosing
Fluorescein angiography
Fundus (uterus)